Kristi Elliott
Family · Concord, CANPI 1972981835
Payments from drug & device makers
Across 101 payments — averaging $22.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$354
- AstraZeneca$346
- Novo Nordisk$216
- Amgen$183
- Lilly USA, LLC$140
- Xeris Pharmaceuticals, Inc.$134
- plus $925 from 18 others
What the payments were for
- Food & beverage$2,28699%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 14 | $354 |
| AstraZeneca(2 entities) | 16 | $346 |
| Novo Nordisk | 15 | $216 |
| Amgen(2 entities) | 7 | $183 |
| Lilly USA, LLC | 5 | $140 |
| Xeris Pharmaceuticals, Inc. | 6 | $134 |
| Corcept Therapeutics | 3 | $126 |
| GSK | 5 | $125 |
| Regeneron Healthcare Solutions, Inc. | 3 | $104 |
| Mannkind Corporation | 4 | $98 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $76 |
| Sanofi-aventis U.S. LLC | 4 | $76 |
| Bayer | 2 | $51 |
| AbbVie | 2 | $47 |
| Insulet Corporation | 2 | $38 |
| Merck | 2 | $36 |
| BD | 1 | $26 |
| Biohaven Pharmaceuticals, Inc. | 1 | $23 |
| Kaleo, Inc. | 1 | $20 |
| Tandem Diabetes Care, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Abbott | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
| Nestle Healthcare Nutrition Inc. | 1 | $14 |
How this compares
$2,298 in reported general payments places this provider in the 85th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 51 | $50,121 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 57 | $38,158 |
| EliquisApixaban | 70 | $34,438 |
| JardianceEmpagliflozin | 47 | $27,204 |
| Spiriva RespimatTiotropium Bromide | 38 | $20,448 |
| Atorvastatin Calcium | 326 | $15,860 |
| LokelmaSodium Zirconium Cyclosilicate | 14 | $10,989 |
| DapagliflozinDapagliflozin Propanediol | 22 | $10,445 |
| Amlodipine Besylate | 355 | $8,021 |
| Duloxetine Hcl | 79 | $7,112 |
| Gabapentin | 247 | $6,664 |
| Donepezil Hcl | 88 | $6,551 |
| Pantoprazole Sodium | 95 | $5,893 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 19 | $5,605 |
| Incruse ElliptaUmeclidinium Bromide | 14 | $5,088 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $216 | $50,12151 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $354 | $47,65285 claims |
| GSKTrelegy Ellipta, Incruse Ellipta | $125 | $43,24671 claims |
| AstraZenecaLokelma | $346 | $10,98914 claims |
| Lilly USA, LLCOlanzapine | $140 | $3,92115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,634 family providers in California.
Other family in Concord
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.